A retrospective study found roxadustat to be more effective in improving hemoglobin levels in patients who had with chronic kidney disease (CKD) compared with recombinant human erythropoietin.
Please provide your email address to receive an email when new articles are posted on . In non-anemic patients, there is a U-shaped association between preoperative hemoglobin level and mortality ...
The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in persons with type 2 diabetes is uncertain. In this trial involving ...
MedPage Today on MSN
Low Hemoglobin Levels Linked to Higher Dementia Risk
Risk peaked when anemia occurred alongside abnormal Alzheimer's biomarkers ...
Phase I/II study of exisulind (E) and vinorelbine (V) in elderly patients with advanced non-small cell lung cancer (NSCLC) ...
Investigating the role of LRP1B in chemo-resistance in advanced triple-negative breast cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a ...
SAN FRANCISCO -- Critically ill patients receiving blood transfusions of 10 or more units had substantially better survival when it brought hemoglobin levels close to normal, according to a ...
Body Fat May Improve Anemia Drug Response Hemoglobin level below 8 mg/dL associated with 82% increased odds of prolonged bleeding time with anemia. In a retrospective study of 1,022 patients with CKD, ...
Novartis (NYSE:NVS) reported detailed results from a phase 3 trial of its oral drug iptacopan to treat certain patients with paroxysmal nocturnal hemoglobinuria (PNH). The study, dubbed APPOINT-PNH, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results